Clinical Trials for Cancer Type: Esophagus

7 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
ECOG-EAY131 (CIRB) Molecular Analysis for Therapy Choice (MATCH) Open
SWOG-S1609 (CIRB) DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors Open
UCI-16-31 [EXEMPT - RETROSPECTIVE] Importin α is a Novel Biomarker of Barrett's Esophagus (BE)-Related Dysplasia & Cancer and Promotes Growth of BE-Derived Cancer Cells by Inducing Aberrant VEGF Expression Open
UCI-16-77 Identification of Features Associated with Dysplasia Using the NvisionVLE® Imaging System Pilot Trial Open
UCI-16-88 Development of Esophageal and Gastric Cancer Patient Derived Xenograft Mouse Models to Investigate Chemotherapy Resistance and Tumor Cell Response Open
UCI-16-96 A Phase 1 Study of the Highly-selective RET Inhibitor, BLU-667, in Patients with Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors Open
UCI-16-99 Coldplay 3: Multi-Center Clinical Study to Evaluate the C2 CryoBalloon™ Focal Ablation System for the Treatment of Patients with Previously-Untreated Dysplastic Barrett's Epithelium Open